Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jeanne Dekdebrun"'
Autor:
Chad Heatwole, Elizabeth Luebbe, Johanna Hamel, Philip Mongiovi, Emma Ciafaloni, Nuran Dilek, William Martens, David Weber, Rashid Hani, Jamie Allen, Claire Smith, Samantha Howell, Spencer Rosero, Katy Eichinger, Linday Baker, Jeanne Dekdebrun, Jim Hilbert, Anika Varma, Michael McDermott, Charles Thornton, Richard Moxley
Publikováno v:
Thursday, April 27.
Publikováno v:
Muscle & Nerve. 66:336-339
Remote study visits (RSVs) are emerging as important tools for clinical research. We tested the feasibility of using RSVs to evaluate patients with myotonic dystrophy type 1 (DM1), including remote quantitative assessment of muscle function, and we a
Autor:
Gayle K, Deutsch, Katharine A, Hagerman, Jacinda, Sampson, Gersham, Dent, Jeanne, Dekdebrun, Dana M, Parker, Charles A, Thornton, Chad R, Heatwole, Sub H, Subramony, Ami K, Mankodi, Tetsuo, Ashizawa, Jeffrey M, Statland, W David, Arnold, Richard T, Moxley, John W, Day
Publikováno v:
Muscle Nerve
Myotonic dystrophy type 1 (DM1) is known to affect cognitive function, but the best methods to assess central nervous system involvement in multicenter studies have not been determined. In this study our primary aim was to evaluate the potential of c
Autor:
Wojciech Zareba, Jeanne Dekdebrun, Nicholas E. Johnson, James E. Hilbert, Christopher A. Beck, Araya Puwanant, William B. Martens, Charles A. Thornton, Michael P. McDermott, Chad Heatwole, Katy Eichinger, Richard T. Moxley, Elizabeth Luebbe, Christine Zizzi, Spencer Rosero, Nuran Dilek, Giovanni Schifitto, Rabi Tawil, J. Franklin Richeson
Publikováno v:
Neurology
ObjectiveTo assess mexiletine's long-term safety and effect on 6-minute walk distance in a well-defined cohort of patients with myotonic dystrophy type 1 (DM1).MethodsWe performed a randomized, double-blind, placebo-controlled trial of mexiletine (15
Autor:
Elizabeth Luebbe, James E. Hilbert, Charles A. Thornton, Nicholas E. Johnson, Rita K. Bode, Jeanne Dekdebrun, Eric L. Logigian, Nuran Dilek, Nan E. Rothrock, Araya Puwanant, Michael P. McDermott, David Victorson, William B. Martens, Katy Eichinger, Chad Heatwole, Richard T. Moxley, Shree Pandya, Barbara G. Vickrey
Publikováno v:
Muscle & Nerve. 53:183-190
Introduction The Myotonic Dystrophy Health Index (MDHI) is a disease-specific patient-reported outcome measure. Here, we examine the associations between the MDHI and other measures of disease burden in a cohort of individuals with myotonic dystrophy
Autor:
Chad, Heatwole, Nicholas, Johnson, Jeanne, Dekdebrun, Nuran, Dilek, Kate, Eichinger, James, Hilbert, Elizabeth, Luebbe, William, Martens, Michael P, Mcdermott, Charles, Thornton, Richard, Moxley
Publikováno v:
Musclenerve.
When preparing for clinical trials in myotonic dystrophy type-1 (DM1), it is important that researchers develop and identify patient-reported outcome measures with good measurement properties.Fifty-two DM1 patients enrolled in 2 clinical studies comp
Autor:
Chad Heatwole, Nicholas E. Johnson, Richard T. Moxley, Mark Heatwole, William B. Martens, Jeanne Dekdebrun, Rita K. Bode, Nan E. Rothrock, Charles A. Thornton, Michael P. McDermott, Elizabeth Luebbe, James E. Hilbert, Nuran Dilek, Barbara G. Vickrey, David Victorson
Publikováno v:
Muscle & Nerve. 49:906-914
Introduction: In preparation for clinical trials we examine the validity, reliability, and patient understanding of the Myotonic Dystrophy Health Index (MDHI). Methods: Initially we partnered with 278 myotonic dystrophy type-1 (DM1) patients and iden
Autor:
Michael P. McDermott, Nicholas E. Johnson, David Victorson, Charles A. Thornton, Jeanne Dekdebrun, Christine Quinn, Rita K. Bode, William B. Martens, Nuran Dilek, Nan E. Rothrock, Elizabeth Luebbe, Chad Heatwole, Richard T. Moxley, Barbara G. Vickrey, James E. Hilbert
Publikováno v:
Neurology. 85(24)
To determine the frequency and relative importance of the most life-affecting symptoms in myotonic dystrophy type 2 (DM2) and to identify the factors that have the strongest association with these symptoms.We conducted a cross-sectional study of adul
Publikováno v:
Neuromuscular Disorders. 23:833
Individuals with myotonic dystrophy (DM) type 1 are less active than healthy individuals, which may result in secondary complications and decreased functional abilities. Therefore, the purpose of this study was to document the physical activity profi
Autor:
W. Martens, Chad Heatwole, Richard T. Moxley, Jeanne Dekdebrun, Nuran Dilek, Charles A. Thornton, Katy Eichinger, Shree Pandya
Publikováno v:
Neuromuscular Disorders. 23:833
Patients with myotonic dystrophy (DM1) have distal upper extremity weakness which initially focuses on the long finger flexors. Grip strength using a Jamar dynamometer with the handle in the second position has provided reliable measurement of hand s